Nanobiotix S.A. (NASDAQ:NBTX) Q4 2025 Earnings Call Transcript April 1, 2026 Operator: Good day, and thank you for standing ...

Since I stepped into the President’s role in June 2025, our focus has been very clear: to accelerate Dyadic International, Inc.’s transition from a development-stage platform company into a commercial ...

Sexual violence causes profound trauma and many victims seek counselling and support in its wake. Access to counselling is crucial to promote recovery for victim-survivors. Like anyone seeking health ...

PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2025 Earnings Call Transcript March 30, 2026 PDS Biotechnology Corporation ...

Ascentage Pharma Group International ( AAPG) Q4 2025 Earnings Call March 26, 2026 8:00 AM EDT Good day, everyone, and welcome to Ascentage Pharma's 2025 Annual Results Earnings Call. [Operator ...

This quarter, MindWalk Holdings Corp. reported its third consecutive year-over-year revenue increase and advanced three ...

Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Full Year 2025 Earnings Conference Call. An audio recording of this webcast will be available shortly after the call today ...

Graphite Bio, Inc. (NASDAQ:GRPH) Q4 2025 Earnings Call Transcript March 24, 2026 Operator: Good morning, ladies and gentlemen, and welcome to the LENZ Therapeutics Year-end 2025 Financial Results ...

The event brought together over 100 stakeholders to discuss new ways to measure college readiness, after decades of the admissions process going relatively unchanged.

Renee Bovelle, MD: I am thrilled and humbled to be the first physician to lead OWL. It is a deep honor and a meaningful responsibility.

CTEXLI approved by FDA for CTX; LIVMARLI approved in Japan for PFIC and Alagille syndrome with partner Takeda; and a single ...